FDA Adverse Event Malfunction Summary report: N

CPS LOCATOR 3D DELIVERY CATHETER

MDR report key: 19934541 · Received August 7, 2024

Report

Report Number
3015970743-2024-00002
Event Type
Malfunction
Date Received
August 7, 2024
Date of Event
May 28, 2024
Report Date
August 7, 2024
Manufacturer
CENTERPOINT SYSTEMS LLC
Product Code
DQY
PMA / PMN Number
K230363
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

UPON RECEIPT OF THE COMPLAINT, CENTERPOINT SYSTEMS IMMEDIATELY REQUESTED ADDITIONAL INFORMATION IN ORDER TO DETERMINE WHAT FURTHER ACTION, IF ANY, IS REQUIRED, AS WELL AS TO CLARIFY WHAT TOOK PLACE DURING THE EVENT. CENTERPOINT HAS NOT RECEIVED ANY ADDITIONAL INFORMATION INDICATION IF/HOW THE DEVICE WAS INVOVLED IN THE PERFORATION AND/OR HOW THE DEVICE MALFUNCITONED. ALTHOUGH THERE IS NO INDICATION OF DEVICE MALFUNCTION OR THAT THE CPS LOCATOR 3D DELIVERY CATHETER WAS DIRECTLY INVOLVED IN THE PERFORATION, CENTERPOINT IS SUBMITTING THIS MEDICAL DEVICE ADVERSE EVENT REPORT OUT OF CAUTION TO ENSURE ALL REGULATORY REQUIREMENTS ARE MET. NO FURTHER INFORMAITON OR CONCLUSIONS ARE AVAILABLE AT THIS TIME.

Description of Event or Problem · 0

PERFORATION OCCURRED WHEN USING LOCATOR 3D. AFTER THE PLACEMENT OF THE MIDDLE SEPTUM OF THE RIGHT VENTRICULAR IN THE NEW IMPLANTATION, THE PATIENT COMPLAINED THAT HE DID NOT FEEL WELL, SO CONTINUOUS PRESSURE MEASUREMENT, FLUOROSCOPY, ECHO, ETC. WERE CONFIRMED. FLUROSCOPICALLY, CONSIDERING THE POSSIBILITY THAT THE PATIENT HAD MOVED FROM THE ATTENTION SEPTUM TO THE HINGE (ALTHOUGH THERE WAS NO PERICARDIAL EFFUSION ON THE ECHO), THE PATIENT'S CONDITION STABLIZED AFTER A THORACOTOMY TO STOP THE BLEEDING SITE. A SUBSITITUTE (EPICARDIAL LEAD) WAS USED AND THE PROCEDURE WAS TERMINATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2396994 CPS LOCATOR 3D DELIVERY CATHETER PERCUTANEOUS CATHETER DQY CENTERPOINT SYSTEMS LLC DS2C200-42 CL12490

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown